Sandbox: malabsorption: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
{| style="border: 0px; font-size: 100%; margin: 3px;" align="center" | {| style="border: 0px; font-size: 100%; margin: 3px;" align="center" | ||
! | |||
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Cause | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Cause | ||
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Peak age of onset | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Peak age of onset | ||
Line 13: | Line 14: | ||
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Gold standard diagnosis | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Gold standard diagnosis | ||
|- | |- | ||
! | |||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Fever | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Fever | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Abdominal pain | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Abdominal pain | ||
Line 18: | Line 20: | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Weight loss | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Weight loss | ||
|- | |- | ||
! | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Watery | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Watery | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Fatty | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Fatty | ||
Line 25: | Line 28: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Other lab findings | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Other lab findings | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Whipple's disease]] | ! align="center" style="background:#DCDCDC;" |[[Whipple's disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |40-60 | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |40-60 | ||
Line 57: | Line 61: | ||
* [[PCR]] testing | * [[PCR]] testing | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Celiac disease]] | ! align="center" style="background:#DCDCDC;" |[[Celiac disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Childhood | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | Childhood | ||
Line 91: | Line 96: | ||
* [[IgA]] tissue transglutaminase antibody | * [[IgA]] tissue transglutaminase antibody | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Tropical sprue]] | ! align="center" style="background:#DCDCDC;" |[[Tropical sprue]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Any age | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | Any age | ||
Line 117: | Line 123: | ||
* Diagnosis of exclusion | * Diagnosis of exclusion | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Crohns disease]] | ! align="center" style="background:#DCDCDC;" |[[Crohns disease]] | ||
| align="center" style="background:#F5F5F5;" | Young adults | | align="center" style="background:#F5F5F5;" | Young adults | ||
Line 144: | Line 151: | ||
* [[Colonoscopy]] with [[biopsy]] | * [[Colonoscopy]] with [[biopsy]] | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Ulcerative colitis]] | ! align="center" style="background:#DCDCDC;" |[[Ulcerative colitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Young adults | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Young adults | ||
Line 179: | Line 187: | ||
* [[Colonoscopy]] with [[biopsy]] | * [[Colonoscopy]] with [[biopsy]] | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]] | ! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Childhood | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Childhood | ||
Line 206: | Line 215: | ||
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | * Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[VIPoma]] | ! align="center" style="background:#DCDCDC;" |[[VIPoma]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |30-50 | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |30-50 | ||
Line 239: | Line 249: | ||
* Followed by imaging | * Followed by imaging | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Zollinger-Ellison syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Zollinger-Ellison syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |20-50 | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |20-50 | ||
Line 261: | Line 272: | ||
* Elevated basal or stimulated serum [[gastrin]]> 120 pg/mL | * Elevated basal or stimulated serum [[gastrin]]> 120 pg/mL | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] | ! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | 30th | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | 30th | ||
Line 287: | Line 298: | ||
* [[Eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]] | * [[Eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]] | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Primary bile acid malabsorption]] | ! align="center" style="background:#DCDCDC;" |[[Primary bile acid malabsorption]] | ||
| align="center" style="background:#F5F5F5;" | Childhood Adult | | align="center" style="background:#F5F5F5;" | Childhood Adult | ||
Line 309: | Line 321: | ||
* Positive [[SeHCAT]] | * Positive [[SeHCAT]] | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Abetalipoproteinemia]] | ! align="center" style="background:#DCDCDC;" |[[Abetalipoproteinemia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Infancy | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Infancy | ||
Line 337: | Line 350: | ||
* Clinical findings and low [[triglyceride]] and [[cholesterol]] level | * Clinical findings and low [[triglyceride]] and [[cholesterol]] level | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]] | ! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |50-70 | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |50-70 | ||
Line 368: | Line 382: | ||
** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells | ** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Hyperthyroidism]] | ! align="center" style="background:#DCDCDC;" |[[Hyperthyroidism]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Any age | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Any age | ||
Line 398: | Line 413: | ||
* [[TSH]] | * [[TSH]] | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]] | ! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Any age | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | Any age | ||
Line 425: | Line 441: | ||
* [[Lactase]] activity assay | * [[Lactase]] activity assay | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Irritable bowel syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Irritable bowel syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |30-50 | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |30-50 | ||
Line 445: | Line 462: | ||
* Diagnosis of exclusion | * Diagnosis of exclusion | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Chronic pancreatitis]] | ! align="center" style="background:#DCDCDC;" |[[Chronic pancreatitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | 50-60 | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | 50-60 | ||
Line 461: | Line 479: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Cirrhosis]] | ! align="center" style="background:#DCDCDC;" |[[Cirrhosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |50-60 | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |50-60 | ||
Line 477: | Line 496: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Short bowel syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Short bowel syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 493: | Line 513: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |Intestinal [[lymphoma]] | ! align="center" style="background:#DCDCDC;" |Intestinal [[lymphoma]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 509: | Line 530: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Agammaglobulinemia]] | ! align="center" style="background:#DCDCDC;" |[[Agammaglobulinemia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 525: | Line 547: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |Intestinal [[lymphangiectasia]] | ! align="center" style="background:#DCDCDC;" |Intestinal [[lymphangiectasia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 541: | Line 564: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Amyloidosis]] | ! align="center" style="background:#DCDCDC;" |[[Amyloidosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 557: | Line 581: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Mastocytosis]] | ! align="center" style="background:#DCDCDC;" |[[Mastocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 573: | Line 598: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |[[Small intestinal bacterial overgrowth]] | ! align="center" style="background:#DCDCDC;" |[[Small intestinal bacterial overgrowth]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 589: | Line 615: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! | |||
! align="center" style="background:#DCDCDC;" |Drug induced [[enteritis]] | ! align="center" style="background:#DCDCDC;" |Drug induced [[enteritis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 605: | Line 632: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
|- | |- | ||
! rowspan="4" |[[Infection]] | |||
! align="center" style="background:#DCDCDC;" |[[HIV AIDS|HIV infection]] | ! align="center" style="background:#DCDCDC;" |[[HIV AIDS|HIV infection]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | |
Revision as of 13:28, 20 November 2017
Abbreviations: WBC: White blood cells; Plt: Platelets, Hgb: Hemoglobin, IgE: Immunoglobulin E, IgA: Immunoglobulin A
Cause | Peak age of onset | History | Physical exam | Lab findings | Additional findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Abdominal pain | Diarrhea | Weight loss | ||||||||||||
Watery | Fatty | WBC | Hgb | Plt | Other lab findings | ||||||||||
Whipple's disease | 40-60 | ± | + | + | + | + |
|
↓ | ↓ | ↓/↑ |
| ||||
Celiac disease | Childhood
Adult |
- | + | ± | ± | + | - | ↓ | - |
|
|
|
|||
Tropical sprue | Any age | + | + | + | + | + |
|
- | ↓ | - |
|
| |||
Crohns disease | Young adults
(20th) |
+ | + | + | + | + | ↑ | ↓ | ↑ |
|
|
|
| ||
Ulcerative colitis | Young adults
(20th) |
+ | + | + | + | + |
|
↑ | ↓ | ↑ |
|
|
|
| |
Cystic fibrosis | Childhood
Adult |
± | + | - | + | + |
|
- | ↓ | - |
|
|
| ||
VIPoma | 30-50 | - | + | + | + | + | - | - | - |
|
|
| |||
Zollinger-Ellison syndrome | 20-50 | - | + | + | + | + | - | ↓ | - |
|
| ||||
Eosinophilic gastroenteritis | 30th | - | + | + | + | + | ↑ | - | - |
|
|
|
| ||
Primary bile acid malabsorption | Childhood Adult | - | + | + | + | + | - | ↓ | - |
|
|
| |||
Abetalipoproteinemia | Infancy
Adult |
- | + | + | + | + | - | - | - |
|
|
|
| ||
Microscopic colitis | 50-70 | - | + | + | - | + | - | ↓ | - |
|
|
|
| ||
Hyperthyroidism | Any age | ± | + | + | - | + | - | - | - |
|
|||||
Lactose intolerance | Any age | - | + | + | - | - | - | - | - |
|
|
| |||
Irritable bowel syndrome | 30-50 | - | ± | ± | ± | - |
|
- | - | - |
| ||||
Chronic pancreatitis | 50-60 | - | + | + | + | + | |||||||||
Cirrhosis | 50-60 | + | + | + | + | + | |||||||||
Short bowel syndrome | |||||||||||||||
Intestinal lymphoma | |||||||||||||||
Agammaglobulinemia | |||||||||||||||
Intestinal lymphangiectasia | |||||||||||||||
Amyloidosis | |||||||||||||||
Mastocytosis | |||||||||||||||
Small intestinal bacterial overgrowth | |||||||||||||||
Drug induced enteritis | |||||||||||||||
Infection | HIV infection | ||||||||||||||
Giardiasis | |||||||||||||||
Strongyloidiasis | |||||||||||||||
Tuberculosis |